CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,532,810 | -25.0% | 1,188,225 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $2,043,747 | +13.9% | 1,188,225 | 0.0% | 0.01% | -8.3% |
| Q1 2023 | $1,794,220 | -11.8% | 1,188,225 | -6.5% | 0.01% | +20.0% |
| Q4 2022 | $2,033,440 | +10.3% | 1,270,900 | 0.0% | 0.01% | -9.1% |
| Q3 2022 | $1,843,000 | -20.8% | 1,270,900 | 0.0% | 0.01% | -69.4% |
| Q2 2022 | $2,326,000 | – | 1,270,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |